Description
BML-210 (also known as CAY10433), is a histone deacetylase (HDAC) inhibitor. BML-210 induces growth inhibition and apoptosis and regulates HDAC and DAPC complex expression levels in cervical cancer cells.
BML-210 (also known as CAY10433), is a histone deacetylase (HDAC) inhibitor. BML-210 induces growth inhibition and apoptosis and regulates HDAC and DAPC complex expression levels in cervical cancer cells.
Alternate Name/Synonyms: N-(2-aminophenyl)-N'-phenyl-octanediamide; CAY10433
Appearance: White to off-white solid
Formulation: N/A
CAS Number: 537034-17-6
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₂₀H₂₅N₃O₂
Molecular Weight: 339.43
Cell-Permeable?: Yes
Purity: ≥98% by HPLC
Solubilities: DMSO (>20 mg/ml)
Handling: Protect from air and light
Country of Origin: USA
Tag Line: A histone deacetylase (HDAC) inhibitor.
MDL Number: MFCD02062139
PubChem CID: 9543540
SMILES: C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NC2=CC=CC=C2N
InChi: InChI=1S/C20H25N3O2/c21-17-12-8-9-13-18(17)23-20(25)15-7-2-1-6-14-19(24)22-16-10-4-3-5-11-16/h3-5,8-13H,1-2,6-7,14-15,21H2,(H,22,24)(H,23,25)
InChi Key: RFLHBLWLFUFFDZ-UHFFFAOYSA-N
Additional Information
Storage Condition: |
-20°C |
Shipping Condition: |
Gel Pack |
Shelf Life: |
36 months |